ACG 2025 24 - 29 October 2025

The Use of Non-Invasive Tests to Characterise the Total Baseline Population in the Phase 3 Essence Trial

Authors :

Laurent Castera^1,2; Kristiane Aasen Engebretsen³; George Boon-Bee Goh^4,5; Elisabetta Bugianesi⁶; Burak Demirel³; Tomáš Koller⁷; Niels Krarup³; Michelle T. Long³; Philip Newsome^8,9; Cláudia Oliveira¹⁰; Vlad Ratziu¹¹; Mary E. Rinella¹²; Michael Roden^13,14,15; Giada Sebastiani^16,17; Arun J. Sanyal¹⁸; on behalf of the ESSENCE study group

Affiliations

View Details Hide Details

Download poster (.pdf)

Keywords

MASH

Congress poster

GLP-1 RA

Semaglutide

PHASE 3 (RCT)

Search Science Hub

Are you a healthcare professional?

The Use of Non-Invasive Tests to Characterise the Total Baseline Population in the Phase 3 Essence Trial